Literature DB >> 17360647

Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics.

Frank Batista1, Daniel Vaiman, Jean Dausset, Marc Fellous, Reiner A Veitia.   

Abstract

FOXL2 is a gene encoding a forkhead transcription factor, whose mutations are responsible for the blepharophimosis-ptosis-epicanthus inversus syndrome that often involves premature ovarian failure. FOXL2 is one of the earliest ovarian markers and it offers, along with its targets, an excellent model to study ovarian development and function in normal and pathological conditions. We have recently shown that the aromatase gene is a target of FOXL2, and only three other targets have been reported so far. To detect potential transcriptional targets of FOXL2, we used DNA chips and quantitative PCR to compare the transcriptomes of granulosa-like cells overexpressing, or not, FOXL2. This analysis showed that mediators of inflammation, apoptotic and transcriptional regulators, genes involved in cholesterol metabolism, and genes encoding enzymes and transcription factors involved in reactive oxygen species detoxification were up-regulated. On the other hand, FOXL2 down-regulated the transcription of several genes involved in proteolysis and signal transduction and in transcription regulation. A bioinformatic analysis was conducted to discriminate between potential target promoters activated and repressed by FOXL2. In addition, the promoters of strongly activated genes were enriched in forkhead recognition sites, suggesting that these genes might be direct FOXL2 targets. Altogether, these results provide insight into the activity of FOXL2 and may help in understanding the mechanisms of pathogenesis of FOXL2 mutations if the targets prove to be the same in the ovary.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360647      PMCID: PMC1805535          DOI: 10.1073/pnas.0611326104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Pax6 is essential for establishing ventral-dorsal cell boundaries in pituitary gland development.

Authors:  C Kioussi; S O'Connell; L St-Onge; M Treier; A S Gleiberman; P Gruss; M G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

2.  Evolution and expression of FOXL2.

Authors:  J Cocquet; E Pailhoux; F Jaubert; N Servel; X Xia; M Pannetier; E De Baere; L Messiaen; C Cotinot; M Fellous; R A Veitia
Journal:  J Med Genet       Date:  2002-12       Impact factor: 6.318

Review 3.  Do oxysterols control cholesterol homeostasis?

Authors:  Ingemar Björkhem
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

4.  Cloning and characterization of a rat ortholog of MMP-23 (matrix metalloproteinase-23), a unique type of membrane-anchored matrix metalloproteinase and conditioned switching of its expression during the ovarian follicular development.

Authors:  J Ohnishi; E Ohnishi; M Jin; W Hirano; D Nakane; H Matsui; A Kimura; H Sawa; K Nakayama; H Shibuya; K Nagashima; T Takahashi
Journal:  Mol Endocrinol       Date:  2001-05

5.  Mammalian GADD34, an apoptosis- and DNA damage-inducible gene.

Authors:  M C Hollander; Q Zhan; I Bae; A J Fornace
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

6.  Transcriptional activation of the human stress-inducible transcriptional repressor ATF3 gene promoter by p53.

Authors:  Chun Zhang; Choungfeng Gao; Junya Kawauchi; Yoshinori Hashimoto; Nobuo Tsuchida; Shigetaka Kitajima
Journal:  Biochem Biophys Res Commun       Date:  2002-10-11       Impact factor: 3.575

7.  Analysis of heterophilic and homophilic interactions of cadherins using the c-Jun/c-Fos dimerization domains.

Authors:  Thomas Ahrens; Olivier Pertz; Daniel Haussinger; Charlotte Fauser; Therese Schulthess; Jurgen Engel
Journal:  J Biol Chem       Date:  2002-03-21       Impact factor: 5.157

8.  Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress.

Authors:  Geert J P L Kops; Tobias B Dansen; Paulien E Polderman; Ingrid Saarloos; Karel W A Wirtz; Paul J Coffer; Ting-T Huang; Johannes L Bos; René H Medema; Boudewijn M T Burgering
Journal:  Nature       Date:  2002-09-19       Impact factor: 49.962

9.  FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation.

Authors:  Elfride De Baere; Diane Beysen; Christine Oley; Birgit Lorenz; Julie Cocquet; Paul De Sutter; Koen Devriendt; Michael Dixon; Marc Fellous; Jean-Pierre Fryns; Arturo Garza; Christoffer Jonsrud; Pasi A Koivisto; Amanda Krause; Bart P Leroy; Françoise Meire; Astrid Plomp; Lionel Van Maldergem; Anne De Paepe; Reiner Veitia; Ludwine Messiaen
Journal:  Am J Hum Genet       Date:  2003-01-14       Impact factor: 11.025

10.  The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome.

Authors:  L Crisponi; M Deiana; A Loi; F Chiappe; M Uda; P Amati; L Bisceglia; L Zelante; R Nagaraja; S Porcu; M S Ristaldi; R Marzella; M Rocchi; M Nicolino; A Lienhardt-Roussie; A Nivelon; A Verloes; D Schlessinger; P Gasparini; D Bonneau; A Cao; G Pilia
Journal:  Nat Genet       Date:  2001-02       Impact factor: 38.330

View more
  31 in total

1.  FOXO1/3 and PTEN Depletion in Granulosa Cells Promotes Ovarian Granulosa Cell Tumor Development.

Authors:  Zhilin Liu; Yi A Ren; Stephanie A Pangas; Jaye Adams; Wei Zhou; Diego H Castrillon; Dagmar Wilhelm; JoAnne S Richards
Journal:  Mol Endocrinol       Date:  2015-06-10

2.  Increased FOXL2 expression alters uterine structures and functions†.

Authors:  Rong Li; San-Pin Wu; Lecong Zhou; Barbara Nicol; John P Lydon; Humphrey H-C Yao; Francesco J DeMayo
Journal:  Biol Reprod       Date:  2020-10-29       Impact factor: 4.285

Review 3.  Minireview: roles of the forkhead transcription factor FOXL2 in granulosa cell biology and pathology.

Authors:  Margareta D Pisarska; Gillian Barlow; Fang-Ting Kuo
Journal:  Endocrinology       Date:  2011-01-19       Impact factor: 4.736

Review 4.  Steroid signaling and temperature-dependent sex determination-Reviewing the evidence for early action of estrogen during ovarian determination in turtles.

Authors:  Mary Ramsey; David Crews
Journal:  Semin Cell Dev Biol       Date:  2008-11-01       Impact factor: 7.727

5.  Microarray analysis of Foxl2 mediated gene regulation in the mouse ovary derived KK1 granulosa cell line: Over-expression of Foxl2 leads to activation of the gonadotropin releasing hormone receptor gene promoter.

Authors:  Jean M Escudero; Jodi L Haller; Colin M Clay; Kenneth W Escudero
Journal:  J Ovarian Res       Date:  2010-02-18       Impact factor: 4.234

6.  Conditional deletion of the retinoblastoma (Rb) gene in ovarian granulosa cells leads to premature ovarian failure.

Authors:  Claudia Andreu-Vieyra; Ruihong Chen; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2008-07-03

7.  C19MC microRNAs regulate the migration of human trophoblasts.

Authors:  Lan Xie; Jean-Francois Mouillet; Tianjiao Chu; W Tony Parks; Elena Sadovsky; Martin Knöfler; Yoel Sadovsky
Journal:  Endocrinology       Date:  2014-09-11       Impact factor: 4.736

8.  Foxl2, a forkhead transcription factor, modulates nonclassical activity of the estrogen receptor-alpha.

Authors:  So-Youn Kim; Jeffrey Weiss; Minghan Tong; Monica M Laronda; Eun-Jig Lee; J Larry Jameson
Journal:  Endocrinology       Date:  2009-09-24       Impact factor: 4.736

9.  Foxl2 functions in sex determination and histogenesis throughout mouse ovary development.

Authors:  José Elias Garcia-Ortiz; Emanuele Pelosi; Shakib Omari; Timur Nedorezov; Yulan Piao; Jesse Karmazin; Manuela Uda; Antonio Cao; Steve W Cole; Antonino Forabosco; David Schlessinger; Chris Ottolenghi
Journal:  BMC Dev Biol       Date:  2009-06-18       Impact factor: 1.978

10.  The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors.

Authors:  Kasmintan A Schrader; Bella Gorbatcheva; Janine Senz; Alireza Heravi-Moussavi; Nataliya Melnyk; Clara Salamanca; Sarah Maines-Bandiera; Susanna L Cooke; Peter Leung; James D Brenton; C Blake Gilks; John Monahan; David G Huntsman
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.